BPG is committed to discovery and dissemination of knowledge
Letter to the Editor Open Access
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Dec 16, 2025; 13(35): 115090
Published online Dec 16, 2025. doi: 10.12998/wjcc.v13.i35.115090
Predictors of intensive care unit admission rates in patients with acute cholangitis
Hyder Osman Mirghani, Department of Internal Medicine, University of Tabuk, Tabuk 51941, Saudi Arabia
Abdelwahab H Hussien, Department of Internal Medicine, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia
ORCID number: Hyder Osman Mirghani (0000-0002-5817-6194).
Author contributions: Mirghani HO conceived and designed the study, conducted the literature search, drafted and made critical revisions to the manuscript, and provided final approval of the version to be published; Hussien AH contributed to drafted and made critical revision.
Conflict-of-interest statement: All authors declare no conflicts of interest.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hyder Osman Mirghani, MD, Professor, Department of Internal Medicine, University of Tabuk, Prince Fahd Bin Sulta, Tabuk 51941, Saudi Arabia. s.hyder63@hotmail.com
Received: October 9, 2025
Revised: October 25, 2025
Accepted: December 3, 2025
Published online: December 16, 2025
Processing time: 69 Days and 23.2 Hours

Abstract

Acute cholangitis (AC) is a heterogeneous disease with considerable variation in clinical presentation and high medical costs. Although the overall mortality rate is decreasing. However, the mortality in severe AC ranged from 10%-30% due to sepsis, multi-organ failure, and systemic inflammatory response syndrome. Assessing the predictors of poor outcomes, including mortality, intensive care unit (ICU) admission, and hospital stay, is vital for early and effective intervention. We assessed the predictors of mortality and ICU admission in patients with AC. We conducted a literature search in PubMed/MEDLINE, Google Scholar, and Cochrane Library for relevant articles. The keywords used were acute cholangitis, biliary cholangitis, predictors, mortality, ICU admission, and Hospital stay. In addition, we assessed the role of early vs late endoscopic retrograde cholangiopancreatography on the outcomes. Old age, end-organ failure, red cell distribution width to albumin ratio, neutrophil-to-lymphocyte ratio, platelet-lymphocyte ratio, the need for ventilator support, diabetes, electrolyte imbalance, procalcitonin-to-albumin ratio, C-reactive protein-to-albumin, Glasgow Coma Scale, and systolic hypertension are predictors of poor outcomes in AC of varying etiology, and concurrent acute pancreatitis was not associated with ICU admission.

Key Words: Acute cholangitis; Predictors; Intensive care unit admission; Mortality; Intensive care unit admission rates

Core Tip: Acute cholangitis (AC) is the infection of the bile and bile ducts, usually resulting from obstruction by stones, benign strictures, and malignancies. AC is a heterogeneous disease with considerable variation in clinical presentation and high medical costs. Literature on AC prognosis is scarce, and studies investigating the indicators of admission to intensive care units are needed for the timely introduction of diagnostic measures and treatment. We gave an important insight regarding the independent predictors of mortality and intensive care unit admission.



TO THE EDITOR

Acute cholangitis (AC) is the infection of the bile and bile ducts, usually resulting from obstruction by stones, benign strictures, and malignancies. AC is divided into mild, moderate, and severe based on experts’ criteria. Despite the progress in its treatment, AC is serious, with mortality observed in 1%-14% of patients depending on severity[1]. AC is a heterogeneous disease with considerable variation in clinical presentation and high medical costs. Although the overall mortality rate is decreasing. However, the mortality in severe AC ranged from 10%-30% due to sepsis, multi-organ failure, and systemic inflammatory response syndrome[2,3].

AC diagnosis and severity grading are based on Tokyo Guidelines first published in 2007 and updated in the years 2013 and 2018. The guidelines are based on systemic inflammation parameters, imaging, and cholestasis with each component further divided in to two items. The definitive diagnosis is fulfilled with positive one item from all the three components, while suspected AC is considered when one item in systemic parameters and one item in either imaging and cholangitis is positive[4,5].

The treatment is antibiotics coverage and biliary drainage, with early biliary drainage significantly improving the prognosis[6]. Importantly, early endoscopic retrograde cholangiopancreatography (ERCP) is associated with mortality reduction and shorter hospital stay when performed in 24-72 hours, with no benefit when conducted in the first 24 hours[7-9].

Literature on AC prognosis is scarce, and studies investigating the indicators of admission to intensive care unit (ICU) are needed for the timely introduction of diagnostic measures and treatment[10,11]. Therefore, we conducted a literature search to assess the predictors of poor outcomes in patients with AC.

We searched PubMed/MEDLINE, Cochrane Library, and Google Scholar for articles assessing the predictors of outcomes, including mortality, hospital stay, and ICU admission in patients with AC. The terms used were AC, biliary cholangitis, predictors, mortality, ICU admission, and Hospital stay. In addition, we assessed the role of early vs late ERCP on the outcomes.

PREDICTORS OF MORTALITY AND ICU ADMISSION IN PATIENTS WITH AC

The predictors of mortality and ICU admission are multifactorial and are affected by the type of hospital, patient’s characteristics including end-organ damage, complete blood count parameters and ratios, patient’s immunity, and sepsis biomarkers. In addition, the etiology of AC, and type and time of intervention significantly affect the outcomes.

Li et al[12] investigated the immune-nutritional markers and inflammatory markers in patients with AC and found that neutrophil-to-lymphocyte ratio (NLR) and prognostic nutritional index are better indicators of AC severity, supporting the findings of Yesil et al[13], who conducted a retrospective study including 633 patients with AC and found an association between platelet-lymphocyte ratio (PLR), NLR, and AC severity. A study conducted in Japan[14] included 699 patients with liver cirrhosis, who were observed to have liver cirrhosis, which is a poor indicator of AC and is associated with high bilirubin and poor albumin recovery. Kozai et al[15] conducted a recent study and found that serum procalcitonin might be a pointer of severity in malignancy-associated AC, but there was no predictive value of procalcitonin in other types of AC. Yagnik et al[16] conducted a study and found that patients with AC admitted to teaching hospitals have higher mortality compared to those admitted to non-teaching hospitals. The authors explained their findings by the higher resident and fellow autonomy in teaching hospitals and the fact that teaching hospitals admitted complex, higher-acuity AC cases.

Huang et al[17] introduced a machine-learning-derived online prediction models for the outcomes with high sensitivity and specificity in which meet the precision requirements of modern diagnosis and treatment compared to the previous models by Pan et al[7], who found that the Glasgow Coma Scale (GCS), oxygen saturation, aspartate transaminase/alanine transaminase ration, serum albumin, glucose, potassium, prothrombin time, and peripheral vascular disease are independent risk factors of severity in AC. Liu et al[18] introduced age, diabetes, ventilator-support time, systolic hypertension, and coagulopathy as indicators for sepsis and mortality, while Inan et al[19] found that old age, low albumin, low platelets count, and low lymphocytes are predictors of severity. Sheng et al[20] in their parsimonious model used sodium, albumin, red cell distribution width, hemoglobin, and the Charlson comorbidity index to predict inflammation, multi-organ failure, and severity. The authors divided AC into inflammatory and non-inflammatory dysfunction types and showed that the inflammatory dysfunction subtype is associated with poor outcomes. The poor outcomes of malignant biliary obstruction compared to biliary stone are obvious, and malignant obstruction is associated with abnormal liver and renal function tests, abnormal white blood cells, and low platelets[21]. Acehan et al[22] found that malignant etiology, creatinine, and red cell distribution width to albumin ratio (RAR) were independent predictors of ICU admission and mortality, RAR score of 3.8 achieved, and sensitivity and specificity of 94.1% and 56.7% respectively, and higher than Tokyo Severity Grading and other prognostic indicators, procalcitonin-to-albumin ratio (PAR), and C-reactive protein to procalcitonin ration for predicting ICU admission.

THE ASSOCIATION OF EARLY ERCP AND DRAINAGE, MORTALITY, AND ICU ADMISSION

The association of early ERCP and drainage and outcomes is controversial and depends on AC severity. Hedjoudje et al[23] found that delayed ERCP (after 24 hours) is associated with ICU admission and mortality, in line with Huang et al[24], Hou et al[25], and Lavillegrand et al[26], who observed lower mortality when ERCP was conducted within 48 hours. Schwed et al[27] found no clinical effects of ERCP timing on adverse outcomes.

AC AND CONCURRENT ACUTE BILIARY PANCREATITIS

Liu et al[28] hypothesized that patients with both AC and concurrent acute biliary pancreatitis (ABP) are expected to exhibit a more pronounced inflammatory response than patients with AC alone and worse clinical outcomes. Then the authors conducted a single-center retrospective study with a two-year duration (358 patients were included). However, the study did not confirm their hypothesis because they found no significant impact of ABP on AC.

The authors were interested in biliary cholangitis and AC; other causes were excluded. The authors rely on the Tokyo criteria 13/18[29] to diagnose AC (systemic inflammation, cholestasis, and imaging). ABP in patients with AC is common and ranges from 18.7% and 23%[30]. We greatly acknowledge Liu et al’s effort despite the limitations of their study[28], including the retrospective design, single-center study, and not including albumin and C-reactive proteins, which significantly limited their results.

The current letter highlighted the importance of revising the Tokyo guidelines for AC to include RAR, NLR, PLR, diabetes, electrolyte imbalance, PAR, and C-reactive protein-to-albumin (CRPAR). In addition, concurrent acute pancreatitis is common, and one in five patients with AC is affected. Although the findings of Liu et al[28] suggested no association between concurrent acute pancreatitis in AC patients and ICU admission. However, the evidence is weak, and further studies on this common association are needed.

CONCLUSION

Old age, end-organ failure, RAR, NLR, PLR, the need for ventilator support, diabetes, electrolyte imbalance, PAR, CRPAR, GCS, and systolic hypertension are predictors of poor outcomes in AC of varying etiology, and concurrent acute pancreatitis was not associated with ICU admission.

ACKNOWLEDGEMENTS

We want to acknowledge the Saudi Digital Library for providing access to its databases. The authors also acknowledge Mohannad Osman for the recording of the audio core tip.

Footnotes

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Gastroenterology and Hepatology

Country of origin: Saudi Arabia

Peer-review report’s classification

Scientific Quality: Grade B

Novelty: Grade A

Creativity or Innovation: Grade B

Scientific Significance: Grade B

P-Reviewer: Bake JF, MD, Assistant Professor, Consultant, Congo S-Editor: Liu JH L-Editor: A P-Editor: Xu J

References
1.  Hocine K, Briant AR, Chaigneau T, Kam W, Collet T, Parienti JJ, Piquet MA, Dupont B. Early prediction of mortality in acute cholangitis: Elaboration of a new simple prognostic score. Hepatobiliary Pancreat Dis Int. 2025;24:535-542.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
2.  Babajide OI, Ogbon EO, Agbalajobi O, Ikeokwu A, Adelodun A, Obomanu ET. Clinical characteristics, predictors, and rates of hospitalized acute cholangitis patients in the United States. Ann Gastroenterol. 2022;35:640-647.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
3.  Beliaev AM, Zyul'korneeva S, Rowbotham D, Bergin CJ. Screening acute cholangitis patients for sepsis. ANZ J Surg. 2019;89:1457-1461.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 2]  [Cited by in RCA: 7]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
4.  Kiriyama S, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Pitt HA, Gouma DJ, Garden OJ, Büchler MW, Yokoe M, Kimura Y, Tsuyuguchi T, Itoi T, Yoshida M, Miura F, Yamashita Y, Okamoto K, Gabata T, Hata J, Higuchi R, Windsor JA, Bornman PC, Fan ST, Singh H, de Santibanes E, Gomi H, Kusachi S, Murata A, Chen XP, Jagannath P, Lee S, Padbury R, Chen MF; Tokyo Guidelines Revision Committee. New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012;19:548-556.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 135]  [Cited by in RCA: 120]  [Article Influence: 9.2]  [Reference Citation Analysis (0)]
5.  Miura F, Okamoto K, Takada T, Strasberg SM, Asbun HJ, Pitt HA, Gomi H, Solomkin JS, Schlossberg D, Han HS, Kim MH, Hwang TL, Chen MF, Huang WS, Kiriyama S, Itoi T, Garden OJ, Liau KH, Horiguchi A, Liu KH, Su CH, Gouma DJ, Belli G, Dervenis C, Jagannath P, Chan ACW, Lau WY, Endo I, Suzuki K, Yoon YS, de Santibañes E, Giménez ME, Jonas E, Singh H, Honda G, Asai K, Mori Y, Wada K, Higuchi R, Watanabe M, Rikiyama T, Sata N, Kano N, Umezawa A, Mukai S, Tokumura H, Hata J, Kozaka K, Iwashita Y, Hibi T, Yokoe M, Kimura T, Kitano S, Inomata M, Hirata K, Sumiyama Y, Inui K, Yamamoto M. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25:31-40.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 318]  [Cited by in RCA: 278]  [Article Influence: 39.7]  [Reference Citation Analysis (0)]
6.  Iqbal U, Khara HS, Hu Y, Khan MA, Ovalle A, Siddique O, Sun H, Shellenberger MJ. Emergent versus urgent ERCP in acute cholangitis: a systematic review and meta-analysis. Gastrointest Endosc. 2020;91:753-760.e4.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 43]  [Cited by in RCA: 44]  [Article Influence: 8.8]  [Reference Citation Analysis (1)]
7.  Pan LN, Pan SA, Hong GL, Chen KW. A New Nomogram for Predicting 30-Day In-Hospital Mortality Rate of Acute Cholangitis Patients in the Intensive Care Unit. Emerg Med Int. 2023;2023:9961438.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 3]  [Reference Citation Analysis (0)]
8.  Comoglu M, Acehan F, Sahiner ES, Camli H, Kilic ZMY, Odemis B, Ates I. Effect of Urgent ERCP on Clinical Outcomes in Acute Cholangitis With Concurrent Acute Gallstone Pancreatitis: A Propensity Score Matching Analysis. J Hepatobiliary Pancreat Sci. 2025;32:591-601.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
9.  Khan R, Marchena-Romero KJ, Ismail MF, Roberts SB, Gimpaya N, Scaffidi MA, Sabrie N, Khalaf K, Mosko J, James P, Forbes N, Razak F, Verma AA, Grover SC. On-site ERCP availability and cholangitis outcomes: Retrospective cohort study. Endosc Int Open. 2025;13:a24947333.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
10.  Kimura Y, Takada T, Strasberg SM, Pitt HA, Gouma DJ, Garden OJ, Büchler MW, Windsor JA, Mayumi T, Yoshida M, Miura F, Higuchi R, Gabata T, Hata J, Gomi H, Dervenis C, Lau WY, Belli G, Kim MH, Hilvano SC, Yamashita Y. TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013;20:8-23.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 122]  [Cited by in RCA: 128]  [Article Influence: 10.7]  [Reference Citation Analysis (0)]
11.  Mukai S, Itoi T, Baron TH, Takada T, Strasberg SM, Pitt HA, Ukai T, Shikata S, Teoh AYB, Kim MH, Kiriyama S, Mori Y, Miura F, Chen MF, Lau WY, Wada K, Supe AN, Giménez ME, Yoshida M, Mayumi T, Hirata K, Sumiyama Y, Inui K, Yamamoto M. Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo Guidelines 2018. J Hepatobiliary Pancreat Sci. 2017;24:537-549.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 87]  [Cited by in RCA: 128]  [Article Influence: 16.0]  [Reference Citation Analysis (0)]
12.  Li D, Sun J, Qi C, Fu X, Gao F. Predicting severity of inpatient acute cholangitis: combined neutrophil-to-lymphocyte ratio and prognostic nutritional index. BMC Gastroenterol. 2024;24:468.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 4]  [Reference Citation Analysis (0)]
13.  Yeşil B, Çalışkan AR, Koşar K, Yüksel M, Gökcan H, Tümtürk A, Köseoğlu HT, Akdoğan Kayhan M. Lymphocyte count and NLR as predictive value for the severity of acute cholangitis. Eur Rev Med Pharmacol Sci. 2023;27:8732-8739.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
14.  Sensui M, Yasui S, Ogasawara S, Kamezaki H, Kan M, Maruta S, Yamada T, Miura Y, Asano K, Shima Y, Nagashima H, Yokoyama M, Kusakabe Y, Sugiyama H, Ohno I, Mikata R, Kato J, Tsuyuguchi T, Kato N. Liver cirrhosis is a risk factor for poor prognosis of acute cholangitis caused by choledocholithiasis. Ann Hepatol. 2022;27:100696.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 4]  [Reference Citation Analysis (0)]
15.  Kozai LA, Nishimura Y, Czech T, Tan AJN, Benavente K, Silangruz K, Fujii-Lau L. Serum Procalcitonin as an Indicator of Disease Severity and Clinical Deterioration in Hospitalized Patients With Acute Cholangitis. Cureus. 2025;17:e89748.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
16.  Yagnik KJ, Patel R, Sonaiya S, Parikh C, Patel P, Shah Y, Hayat U, Dahiya DS, Radadiya D, Bharadwaj HR, Du D, Terrany B, Kaswala D, Confer B, Khara HS. Impact of Hospital Teaching Status on Outcomes of Acute Cholangitis: A Propensity-Matched Analysis of Hospitalizations in the United States. Gastroenterology Res. 2025;18:129-138.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
17.  Huang S, Zhou Y, Liang Y, Ye S, Zhu A, Li J, Bai X, Yue C, Feng Y. Machine-learning-derived online prediction models of outcomes for patients with cholelithiasis-induced acute cholangitis: development and validation in two retrospective cohorts. EClinicalMedicine. 2024;76:102820.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 6]  [Reference Citation Analysis (0)]
18.  Liu Q, Zhou Q, Song M, Zhao F, Yang J, Feng X, Wang X, Li Y, Lyu J. A nomogram for predicting the risk of sepsis in patients with acute cholangitis. J Int Med Res. 2020;48:300060519866100.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 5]  [Cited by in RCA: 7]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
19.  Inan O, Sahiner ES, Ates I. Factors associated with clinical outcome in geriatric acute cholangitis patients. Eur Rev Med Pharmacol Sci. 2023;27:3313-3321.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
20.  Sheng Y, Xu S, Zhang S, Zhang D. The relationship between clinical subtypes, prognosis, and treatment in ICU patients with acute cholangitis using unsupervised machine learning methods. BMC Infect Dis. 2025;25:979.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
21.  Tsou YK, Su YT, Lin CH, Liu NJ. Acute cholangitis: Does malignant biliary obstruction vs choledocholithiasis etiology change the clinical presentation and outcomes? World J Clin Cases. 2023;11:6984-6994.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 7]  [Reference Citation Analysis (0)]
22.  Acehan F, Camli H, Kalkan C, Tez M, Demir BF, Altiparmak E, Ates I. Red cell distribution width-to-albumin ratio is a simple promising prognostic marker in acute cholangitis requiring biliary drainage. Hepatobiliary Pancreat Dis Int. 2024;23:487-494.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 2]  [Cited by in RCA: 4]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
23.  Hedjoudje A, Cheurfa C, Et Talby M, Levy P, Prat F, Piton G. Outcomes and predictors of delayed endoscopic biliary drainage for severe acute cholangitis due to choledocholithiasis in an intensive care unit. Dig Liver Dis. 2023;55:763-770.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 2]  [Cited by in RCA: 7]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
24.  Huang YC, Wu CH, Lee MH, Wang SF, Tsou YK, Lin CH, Sung KF, Liu NJ. Timing of endoscopic retrograde cholangiopancreatography in the treatment of acute cholangitis of different severity. World J Gastroenterol. 2022;28:5602-5613.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in CrossRef: 6]  [Cited by in RCA: 5]  [Article Influence: 1.7]  [Reference Citation Analysis (2)]
25.  Hou LA, Laine L, Motamedi N, Sahakian A, Lane C, Buxbaum J. Optimal Timing of Endoscopic Retrograde Cholangiopancreatography in Acute Cholangitis. J Clin Gastroenterol. 2017;51:534-538.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 31]  [Cited by in RCA: 31]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
26.  Lavillegrand JR, Mercier-Des-Rochettes E, Baron E, Pène F, Contou D, Favory R, Préau S, Galbois A, Molliere C, Miailhe AF, Reignier J, Monchi M, Pichereau C, Thietart S, Vieille T, Piton G, Preda G, Abdallah I, Camus M, Maury E, Guidet B, Dumas G, Ait-Oufella H. Acute cholangitis in intensive care units: clinical, biological, microbiological spectrum and risk factors for mortality: a multicenter study. Crit Care. 2021;25:49.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 4]  [Cited by in RCA: 30]  [Article Influence: 7.5]  [Reference Citation Analysis (0)]
27.  Schwed AC, Boggs MM, Pham XD, Watanabe DM, Bermudez MC, Kaji AH, Kim DY, Plurad DS, Saltzman DJ, de Virgilio C. Association of Admission Laboratory Values and the Timing of Endoscopic Retrograde Cholangiopancreatography With Clinical Outcomes in Acute Cholangitis. JAMA Surg. 2016;151:1039-1045.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 21]  [Cited by in RCA: 26]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
28.  Liu KT, Lee MH, Lin CH, Tsou YK, Sung KF, Wang SF, Wu CH, Liu NJ. Acute cholangitis due to common bile duct stones: Clinical outcomes in patients with and without concurrent acute pancreatitis. World J Clin Cases. 2025;13:110553.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
29.  Kiriyama S, Kozaka K, Takada T, Strasberg SM, Pitt HA, Gabata T, Hata J, Liau KH, Miura F, Horiguchi A, Liu KH, Su CH, Wada K, Jagannath P, Itoi T, Gouma DJ, Mori Y, Mukai S, Giménez ME, Huang WS, Kim MH, Okamoto K, Belli G, Dervenis C, Chan ACW, Lau WY, Endo I, Gomi H, Yoshida M, Mayumi T, Baron TH, de Santibañes E, Teoh AYB, Hwang TL, Ker CG, Chen MF, Han HS, Yoon YS, Choi IS, Yoon DS, Higuchi R, Kitano S, Inomata M, Deziel DJ, Jonas E, Hirata K, Sumiyama Y, Inui K, Yamamoto M. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25:17-30.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 468]  [Cited by in RCA: 463]  [Article Influence: 66.1]  [Reference Citation Analysis (0)]
30.  Neoptolemos JP, Carr-Locke DL, Leese T, James D. Acute cholangitis in association with acute pancreatitis: incidence, clinical features and outcome in relation to ERCP and endoscopic sphincterotomy. Br J Surg. 1987;74:1103-1106.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 49]  [Cited by in RCA: 42]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]